Natus Medical Inc. received U.S. Food and Drug Administration 510(k) clearance for the Quantum amplifier—a high-channel count amplifier that has applications in epilepsy and seizure monitoring along with research applications.
According to the company, Quantum is the first amplifier in the market to offer up to 256 channels in a compact, wearable package. Quantum, Natus officials claim, also is the first compact amplifier to feature up to 16 kHz sampling rates providing increased visibility of faster brain frequencies combined with a software-controlled digital switch matrix facilitating functional brain mapping through cortical stimulation and a dual data stream for an efficient clinical and research workflow.
"Natus is committed to working with healthcare providers and leading academic institutions to develop breakthrough solutions and improve patient care. This new product is a quantum leap in amplifier technology and is a great example of our commitment," said Jim Hawkins, CEO and president of Natus. "The Quantum amplifier compliments our market leading neurodiagnostic product line in use today by epilepsy centers, EEG labs, sleep disorder centers, emergency rooms and intensive care units worldwide."
Pleasanton, Calif.-based Natus makes products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in neurological dysfunction, newborn care and hearing impairment.